A formulation of a conjugate of a tubulysin analog to a cell-binding molecule
US-2026091081-A1 · Apr 2, 2026 · US
Hangzhou Dac Biotech Co Ltd holds 77 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 77 |
| Recent patents | 18 |
| First publication | Sep 10, 2015 |
| Latest publication | Apr 2, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026091081-A1 · Apr 2, 2026 · US
US-12576124-B2 · Mar 17, 2026 · US
US-12508321-B2 · Dec 30, 2025 · US
US-12496351-B2 · Dec 16, 2025 · US
US-12478695-B2 · Nov 25, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026091081-A1 · Apr 2, 2026 · US
US-12576124-B2 · Mar 17, 2026 · US
US-12508321-B2 · Dec 30, 2025 · US
US-12496351-B2 · Dec 16, 2025 · US
US-12478695-B2 · Nov 25, 2025 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 77 |
| Chemistry & Metallurgy | 73 |
| Cross-Sectional Technologies | 29 |
| Physics | 3 |
Answers are generated from the same data shown on this page.